InvestorsHub Logo
Followers 6
Posts 136
Boards Moderated 0
Alias Born 05/08/2014

Re: Evaluate post# 15798

Tuesday, 07/22/2014 4:58:22 PM

Tuesday, July 22, 2014 4:58:22 PM

Post# of 718771
Hi Evaluate,

I noticed the part about abbreviated assessment for orphan drugs, but I wanted to be conservative when assessing the first potential $ sales could roll in from Germany. Thus, I took a very conservative approach and assumed the benefit assessment and price negotiation were still outstanding as of Feb 21st.

With regards to the 12-month "Preparation Phase", I am assuming most of the data was gathered and packaged for the German PEI would be sufficient for the benefits assessment.  This is an assumption on my part and not something I am completely sure about.

Thanks
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News